The update reads, Use of WEGOVY has been associated with gastrointestinal adverse reactions, sometimes severe
it is associated with significant increase in the incidence of stroke, AF recurrence, and cardiovascular mortality
Safety and tolerability were predefined as the primary endpoint and assessed by treatment-emergent adverse events (TEAEs)
Since the carrier molecule of fatty acids, acyl-CoA, can not cross the cell membrane of the mitochondria, a deficiency of carnitine causes a reduction in the concentration of fatty acids in the mitochondria and, consequently, a reduced production of energy
Powerful Anti-Inflammatory Anti-inflammatory benefits have been evidenced with BPC-157 administration in many tissue types, including the lungs, liver, nervous system, and gastrointestinal tract [33, 34]
Vitamin C Boosts skin radiance & supports collagen production